Plant Based Protein and Whey Protein: Effects on Body Composition and Performance
4BettPro
Comparing the Effects of Plant Based Protein vs. Whey Protein on Performance and Body Composition of Futsal Players
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aimed to investigate the effects of a newly developed plant-based protein blend regarding health and safety, body composition, and performance on healthy and physically active adult individuals, specifically team sports athletes. A randomized, double-blind, controlled trial was used to compare the effects of the plant-based protein versus whey protein, after an 8-week supplementation protocol, on body composition, biochemical markers, muscle strength and power, as well as aerobic performance in male futsal players. The working hypothesis is that this special blend of plant-based protein will be equivalent to whey protein, not only regarding body composition and performance, but also insofar as health and safety at the biochemical and physiological level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2021
CompletedFirst Submitted
Initial submission to the registry
January 13, 2022
CompletedFirst Posted
Study publicly available on registry
February 8, 2022
CompletedFebruary 8, 2022
January 1, 2022
3 months
January 13, 2022
January 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (17)
Body composition parameter - change in fat free mass (FFM)
FFM (kg) was assessed by dual energy X-ray absorptiometry
Baseline, week 4 and week 8
Body composition parameter - change in fat mass (FM)
FM (%) was assessed by dual energy X-ray absorptiometry
Baseline, week 4 and week 8
Body composition parameter - change in muscle thickness
muscle thickness of the rectus femoris (mm) was assessed by ultrasonography
Baseline, week 4 and week 8
Body composition parameter - change in body water
total body water, intracellular water and extracellular water (L) were assessed by bioelectrical impedance analysis
Baseline, week 4 and week 8
Performance parameter - change in strength
Maximal isometric forearm strength (N) was assessed using a handgrip dynamometer
Baseline, week 4 and week 8
Performance parameter - change in maximum strength
Maximum strength (kg) was predicted from 1-RM in back squat and bench press exercises using a Multipower machine withVitruve technology
Baseline, week 4 and week 8
Performance parameter - change in peak power
Muscle power (Watt) was assessed with a supramaximal cycling test on cycle ergometer
Baseline, week 4 and week 8
Performance parameter - change in jump height
Vertical jump height (cm) was assessed on a multicomponent force platform interfaced with the Chronojump software
Baseline, week 4 and week 8
Aerobic performance - change in Oxygen uptake
VO2peak (mL.kg-1.min-1) was assessed using breath-by-breath gas analyzer in an incremental test performed on a treadmill
Baseline, week 4 and week 8
Aerobic performance - change in Oxygen uptake
Maximal aerobic speed (km/h) was assessed in an incremental test performed on a treadmill
Baseline, week 4 and week 8
biochemical health markers - change in cortisol
Salivary cortisol was assessed using spectrophotometry techniques in an automated equipment.
Baseline, week 4 and week 8
biochemical health markers - change in creatinine
plasma creatinine was assessed using spectrophotometry techniques in an automated equipment.
Baseline, week 4 and week 8
biochemical health markers - change creatine kinase
plasma creatine kinase was assessed using spectrophotometry techniques in an automated equipment.
Baseline, week 4 and week 8
biochemical health markers - change in glucose
plasma glucose was assessed using spectrophotometry techniques in an automated equipment.
Baseline, week 4 and week 8
biochemical health markers - change in C reactive protein
plasma C Reactive Protein was assessed using spectrophotometry techniques in an automated equipment.
Baseline, week 4 and week 8
biochemical health markers - change in Aspartate Aminotransferase
plasma Aspartate Aminotransferase was assessed using spectrophotometry techniques in an automated equipment.
Baseline, week 4 and week 8
biochemical health markers - change in alanine aminotransferase
Plasma alanine aminotransferase was assessed using spectrophotometry techniques in an automated equipment.
Baseline, week 4 and week 8
Secondary Outcomes (2)
Body composition parameter - change in phase angle
Baseline, week 4 and week 8
Body composition parameter - change of visceral fat
Baseline, week 4 and week 8
Study Arms (2)
Plant based protein
EXPERIMENTALWhey Protein
EXPERIMENTALInterventions
A single dose of \~30 g of a plant-based protein blend was ingested 30-60 min after physical practice in training days or 30-60 min before bedtime in resting days.
A single dose of \~30 g of whey protein was ingested 30-60 min after physical practice in training days or 30-60 min before bedtime in resting days.
Eligibility Criteria
You may qualify if:
- Subjects currently engaged in a Futsal training program in a competition team, currently engaged in practice for at least 1 year and at least 3 times per week.
You may not qualify if:
- Individuals taking any type of drug (including anabolic steroids), medicines or supplements that may enhance body composition or performance, 3 months prior to the beginning of the trial.
- Clinical diagnose of a disease that might compromise tolerance to the supplements or influence body composition or performance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bettery S.A.lead
Study Sites (1)
Bettery S.A.
Oeiras, Porto Salvo, 2740-262, Portugal
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Innovation Manager
Study Record Dates
First Submitted
January 13, 2022
First Posted
February 8, 2022
Study Start
September 1, 2021
Primary Completion
December 10, 2021
Study Completion
December 10, 2021
Last Updated
February 8, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share